Effect of sulfonylurea drugs on plasma free fatty acid and blood glucose concentrations in man.
D000092:Acetohexamide / Q000494:pharmacology; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000503:physiopathology*; D005215:Fasting; D005227:Fatty Acids / Q000378:metabolism*; D005990:Glycerol / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D010629:Phenformin / Q000494:pharmacology*; D010919:Placebos; D051381:Rats; D013411:Sulfadiazine / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology*
D001786:Blood Glucose; D005227:Fatty Acids; D010919:Placebos; D013411:Sulfadiazine; D014044:Tolbutamide; D010629:Phenformin; D005990:Glycerol; D000092:Acetohexamide